NCT04245280View on ClinicalTrials.gov

Effectiveness of PENG Block Combined to LFCN Block on the Quality of Recovery After Total Hip Replacement

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Total Hip Replacement SurgeryPostoperative Pain
Interventions
DRUG

Ropivacaine 0.5% Injectable Solution

ropivacaine 0.5% with epinephrine 2.5 mcg/ml

DRUG

Saline Solution

normal saline solution (NaCl 0.9%)

Trial Locations (1)

H2X 3E4

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER